The therapeutic modulation of p75NTR has gained attention in the neurological research field, particularly evidenced by studies where blocking p75NTR with pharmacological agents like LM11A-31 and EVT901 led to improved outcomes in brain injury animal models [25,31]. The gene discussed is NGFR; the disease is brain injury.